Results 11 to 20 of about 128,242 (175)

Primary Testicular Carcinoid Tumor presenting as Carcinoid Heart Disease

Indian Journal of Urology, 2015
Primary carcinoid tumors of the testis are very rare, and they seldom present with carcinoid syndrome. We report a hereto unreported instance, where a patient with a long-standing testicular mass presented with carcinoid heart disease, an uncommon form ...
Manjunath L Chikkaraddi, Sudeep Krishna, Manjunath Shetty   +2 more
doaj   +2 more sources

Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR

Case Reports in Oncological Medicine, 2017
We present a case of metastatic recurrence of carcinoid tumor accompanied by carcinoid syndrome in a 68-year-old Japanese man, 12 years after resection of typical pulmonary carcinoid.
Asako Yanagisawa, Satoshi Hirano, Shinichiro Shimizu, Takuma Hiroishi, Kohei Shikano, Noriko Hayama, Tetsuo Fujita, Hiroyuki Amano, Makoto Nakamura, Sukeyuki Nakamura, Hiroshi Tabeta   +10 more
doaj   +3 more sources

Endobronchial Carcinoid and Concurrent Carcinoid Syndrome in an Adolescent Female [PDF]

Case Reports in Pediatrics, 2016
Endobronchial carcinoid tumors are the most common intrabronchial tumors in children and adolescents. Common signs and symptoms include persistent cough and wheezing not responsive to bronchodilators, hemoptysis, and recurrent fever.
Jonathan D. Cogen, Jonathan Swanson, Thida Ong   +2 more
doaj   +2 more sources

A rare case of metastatic renal carcinoid [PDF]

BMC Urology, 2010
Background Carcinoid is an endocrine cell tumor with low-grade atypia, which is generally a low-grade malignant cancer with a good prognosis. Metastatic renal carcinoid is even rarer than primary carcinoids. Case presentation We present our experience of
Tobiume Motoi, Katsuda Remi, Zennnami Kenji, Yoshizawa Takahiko, Nishikawa Genya, Yamada Yoshiaki, Nakamura Kogenta, Kato Yoshiharu, Aoki Shigeyuki, Taki Tomohiro, Honda Nobuaki   +10 more
doaj   +3 more sources

Primary Mesenteric Carcinoid Tumor Presenting with Carcinoid Syndrome [PDF]

Case Reports in Gastroenterology, 2018
Neuroendocrine neoplasms (NENs) are a diverse group of tumors arising throughout the body with a common origin from neuroendocrine cells. Well-differentiated NENs, also known as neuroendocrine tumors (NETs), are generally indolent and are often found ...
Oluwaseun Shogbesan, Abdullateef Abdulkareem, Binu Pappachen, John Altomare   +3 more
doaj   +2 more sources

Carcinoid Syndrome-Induced Ventricular Tachycardia [PDF]

Case Reports in Cardiology, 2016
Introduction. Carcinoid tumors are rare neuroendocrine malignancies that secrete multiple bioactive substances. These bioactive substances are responsible for the carcinoid syndrome characterized by diarrhea, flushing, syncope, and right-sided valvular ...
Austin B. Rupp, Abdulmohsin Ahmadjee, Jack H. Morshedzadeh, Ravi Ranjan   +3 more
doaj   +2 more sources

ECHOCARDIOGRAPHIC DIAGNOSTICS OF CARCINOID HEART DISEASE [PDF]

Zdravniški Vestnik, 2002
Background. Carcinoid heart disease is a rare heart disease which affects endocard and heart valves on the right side of heart. It affects only patients with manifested carcinoid syndrome, which is thought to be the consequence of secretory active ...
Janez Ravnik, Maja Podlesnik, Saša Markovič, Mirta Koželj   +3 more
doaj   +1 more source

Central Airway Carcinoid Tumorlets Following Resection of a Typical Carcinoid Tumor

Diagnostics
Pulmonary neuroendocrine proliferations and neoplasms represent a broad spectrum of diseases, ranging from neuroendocrine cell hyperplasia and tumorlets to carcinoid tumors.
Kyungsoo Bae, Kyung Nyeo Jeon, I Re Heo, Hyo Jung An, Dae Hyun Song   +4 more
doaj   +2 more sources

Simultaneous surgical treatment of primary ovarian carcinoid and carcinoid heart disease

, 2022
The incidence of neuroendocrine tumors (NET) is 2.5–5 per 100 000 population. Up to 20% of patients with NET develop carcinoid syndrome (CS), and in 40–50% of those carcinoid heart disease (CHD) is reported (0.27 per 100 000 population per year) [1 ...
Uladzimir Andrushchuk, Mikalai Shchatsinka, Aliaxandr Saevich, Viktoria Ermochenko   +3 more
core   +1 more source

Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21(waf1/cip1) [PDF]

, 2001
Background/Aims: We investigated the effect of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist pioglitazone on growth and TRAIL-induced apoptosis in carcinoid cells.
Göke, Burkhard, Göke, Rüdiger, Chen, Youhai, El-Deiry, Wafik S., Göke, Alexandra   +4 more
core   +1 more source